SCHEMBL28628662

SCHEMBL28628662

CC(CN(C)C)CS(=O)(=O)N[Si](c1ccccc1)(c1ccccc1)C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 1/20 0.34
▸ CYP2D6 P10635 3/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ HTR2A P28223 2/20 0.33
▸ HRH1 P35367 2/20 0.33
▸ TDP1 Q9NUW8 1/20 0.32
▸ SLC6A2 P23975 3/20 0.31
▸ SLC6A4 P31645 3/20 0.31
▸ SLC6A3 Q01959 3/20 0.31
▸ CYP3A4 P08684 3/20 0.31
▸ PTGES2 Q9H7Z7 1/20 0.30
▸ CHRM1 P11229 3/20 0.30
▸ ADRA1A P35348 3/20 0.30
▸ DRD3 P35462 3/20 0.30
▸ KCNH2 Q12809 3/20 0.30
▸ CHRM2 P08172 2/20 0.30
▸ HTR1A P08908 2/20 0.30
▸ ADRA2A P08913 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28613140 0.84 PTGES2 (0.32) PTGES2
SCHEMBL22280042 0.72 CYP2D6 (0.32) RAB9ACYP2D6HSD17B10ALDH1A1CYP2C19
SCHEMBL22266027 0.70 KEAP1 (0.41) HSD17B10ALDH1A1TDP1LMNAKMT2A
SCHEMBL22266023 0.70 ALDH1A1 (0.33) ALDH1A1
SCHEMBL25014616 0.69 KCNN4 (0.37) HSD17B10OPRM1MEN1KMT2A
SCHEMBL22280136 0.68 SFRP1 (0.33) RAB9AALDH1A1HTR2AHRH1LMNA
SCHEMBL21962888 0.68 GAA (0.38) ALDH1A1SLC6A3ADRA1ATBXA2RLMNA
SCHEMBL21962953 0.67 LMNA (0.41) HSD17B10ALDH1A1TDP1LMNATSHR
SCHEMBL21962948 0.65 LMNA (0.39) RAB9AALDH1A1TDP1LMNATSHR
SCHEMBL21962605 0.64 NR1I2 (0.39) CYP2D6ALDH1A1CYP2C19TDP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113316566-A Compounds and compositions for treating conditions associated with NLRP activity 诺华股份有限公司 2021-08-27 — — CN disclosed
Send feedback